Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Adam Bagg, MD

Adam Bagg, MD Physician

Director, Hematology Director, Minimal Residual Disease Resource Laboratory Medical Director, Cytogenetics Laboratory Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Bagg is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

About Dr. Adam Bagg

Recognized by America's Top Doctors, 2010, 2012 - 2018

Recognized annually in Philadelphia magazine's Top Docs issues from 2010 - 2019

My clinical expertise is in Laboratory Hematology; Laboratory Evaluation of Hematologic Diseases; Leukemias; Lymphomas; Myelodysplastic Syndromes; Molecular Pathology; Myeloma; Hodgkin lymphoma.

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Pathology - Clinical Pathology, 1992
  • Pathology - Hematology, 1999

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of the Witwatersrand School
Residency: Johannesburg General Hospital/Witwatersrand University
Residency: University of Witwatersrand and South
Residency: Georgetown University Medical Center
Fellowship: Georgetown University Medical Center


American Association for Cancer Research, National American Society of Hematology, National Association for Molecular Pathology, National European Bone Marrow Working Group, National Hematopathology Service, Boca Raton Regional Hospital, Boca Raton, FL, National Recommendations for the Work-up of Lymphoma, International Society of Hematopathology, National United States and Canadian Academy of Pathology, National

Hospital Affiliation

Dr. Bagg is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Molecular genetics and pathology of Leukemias and Lymphomas; Myelodysplastic syndromes; Minimal residual disease; Hodgkin lymphoma

Selected Publications:

Baraban E, Sadigh S, Rosenbaum J, Van Arnam J, Bogusz AM, Mehr C, Bagg A.: Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease. Br J Haematol. : 2019.

Caponetti GC, Bagg A: Genetic studies in the evaluation of myeloproliferative neoplasms. Semin Hematol. : 2019.

Kluk MJ, Bagg A: Expedited analysis and reporting of multiple mutations that modify medical management in myeloid malignancies: It's about (turn-around) time! Journal of Molecular Diagnostics : 2019.

Salehi S, Astle JM, Sadigh S, Lake J, Aikawa V, Tang G, Wang SA, Bagg A.: Myeloid neoplasm with eosinophilia and PCM1-JAK2 associated with acute promyelocytic leukemia with PML-RARA. Leuk Lymphoma. : 2019.

Sadigh S, Morrissette JJD, Bagg A.: FBXW7 mutations in acute myeloid leukemia. Leuk Lymphoma : 2019.

Wang J, Rea B, Haun P, Emerson R, Kirsch I, Bagg A.: High-Throughput Sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology : 2018.

Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A.: Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Modern Pathology : 2018.

Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A.: Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol. : 2018.

Aynardi J, Manur R, Hess PR, Chekol S, Morrissette JJD, Babushok D, Hexner E, , Rogers HJ, Hsi ED, Margolskee E, Orazi A, Hasserjian R, Bagg A.: JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group. Br J Haematol. : 2018.

Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S.: Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell : 2018.

160., Ohgami RS, Rosenwald A, Bagg A: Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions Journal of Molecular Diagnostics : 2019.

Academic Contact Info

Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
Division of Hematopathology
7.017 Gates Pavilion
3400 Spruce Street

Philadelphia, PA 19104-4283
Phone: (215) 662-4280
Patient appointments: 800-789-7366 (PENN)

Related Links